Oteri et al., 2016 - Google Patents
Does vitamin D3 have an impact on clinical and biochemical parameters related to third molar surgeryOteri et al., 2016
- Document ID
- 7002007412153055641
- Author
- Oteri G
- Cicciù M
- Peditto M
- Catalano A
- Loddo S
- Pisano M
- Lasco A
- Publication year
- Publication venue
- Journal of Craniofacial Surgery
External Links
Snippet
Does Vitamin D3 Have an Impact on Clinical and Biochemical P... : Journal of Craniofacial
Surgery Does Vitamin D3 Have an Impact on Clinical and Biochemical Parameters Related to
Third Molar Surgery : Journal of Craniofacial Surgery Log in or Register Subscribe to …
- 210000004357 Molar, Third 0 title abstract description 21
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Oteri et al. | Does vitamin D3 have an impact on clinical and biochemical parameters related to third molar surgery | |
| Rizzoli et al. | The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) | |
| Radominski et al. | Brazilian guidelines for the diagnosis and treatment of postmenopausal osteoporosis | |
| Koundourakis et al. | Muscular effects of vitamin D in young athletes and non-athletes and in the elderly | |
| Peichl et al. | Parathyroid hormone 1-84 accelerates fracture-healing in pubic bones of elderly osteoporotic women | |
| Virk et al. | Systemic administration of sclerostin antibody enhances bone repair in a critical-sized femoral defect in a rat model | |
| Fallucco et al. | Primary reconstruction of alveolar clefts using recombinant human bone morphogenic protein-2: clinical and radiographic outcomes | |
| Mason et al. | Effects of vitamin D3 supplementation on lean mass, muscle strength, and bone mineral density during weight loss: a double‐blind randomized controlled trial | |
| Haroon et al. | Vitamin D deficiency: subclinical and clinical consequences on musculoskeletal health | |
| Castelo-Branco et al. | Use of ossein–hydroxyapatite complex in the prevention of bone loss: a review | |
| Lane | Osteoporosis: Medical prevention and treatment | |
| Anyanechi et al. | Spontaneous bone regeneration after segmental mandibular resection: a retrospective study of 13 cases | |
| Bernick et al. | Parameters for lithium treatment are critical in its enhancement of fracture-healing in rodents | |
| Dixon et al. | Calcium and vitamin D use among adults in periodontal disease maintenance programmes | |
| US9827273B2 (en) | Preparation and method for the prophylaxis and treatment of atypical osteoporosis | |
| Gatt et al. | The effect of vitamin D supplementation for bone healing in fracture patients: a systematic review | |
| Haworth | Impact of cystic fibrosis on bone health | |
| Schoenmakers et al. | Vitamin D and acute and severe illness–a mechanistic and pharmacokinetic perspective | |
| von Scheven et al. | Vitamin D supplementation in the pediatric rheumatology clinic | |
| Thakeb et al. | Bone transport for the management of severely comminuted fractures without bone loss | |
| Dempewolf et al. | What Are the Barriers to Incorporating Nutrition Interventions Into Care of Older Adults With Femoral Fragility Fractures? | |
| Songpatanasilp et al. | Open-label study of treatment with alendronate sodium plus vitamin D in men and women with osteoporosis in Thailand | |
| Saadon | Vitamin D Deficiency in Childhood: A Review | |
| Tanaka et al. | Bone atrophy at high altitude | |
| Bardosono et al. | Relevance of calcium and vitamin D in supporting bone health: An expert panel recommendation in Indonesia |